Vimta Labs Limited Market Cap ($251.20 Million)
Market Cap & Net Worth: Vimta Labs Limited (VIMTALABS)
Vimta Labs Limited market cap. Vimta Labs Limited (NSE:VIMTALABS) has a market capitalization of $251.20 Million (Rs23.23 Billion) as of October 31, 2026. Listed on the NSE stock exchange, this India-based company holds position #15475 globally and #779 in its home market, demonstrating a 6.39% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Vimta Labs Limited's stock price Rs519.80 by its total outstanding shares 44686904 (44.69 Million).
Vimta Labs Limited Market Cap History (2015–2026)
Vimta Labs Limited market cap history from 2015 to 2026. Data shows growth from $46.99 Million to $251.20 Million (18.80% CAGR). Check Vimta Labs Limited (VIMTALABS) stock price for real-time trading data and today's change.
Vimta Labs Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Vimta Labs Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see VIMTALABS cash generation efficiency for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
0.06x
Vimta Labs Limited's market cap is 0.06 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.32x
Vimta Labs Limited's market cap is 0.32 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $77.77 Million | $1.54 Billion | $105.92 Million | 0.05x | 0.73x |
| 2018 | $146.52 Million | $1.83 Billion | $164.33 Million | 0.08x | 0.89x |
| 2019 | $43.81 Million | $2.13 Billion | $253.11 Million | 0.02x | 0.17x |
| 2020 | $82.18 Million | $1.81 Billion | $68.45 Million | 0.05x | 1.20x |
| 2021 | $194.74 Million | $2.09 Billion | $214.05 Million | 0.09x | 0.91x |
| 2022 | $209.06 Million | $2.76 Billion | $413.30 Million | 0.08x | 0.51x |
| 2023 | $194.26 Million | $3.15 Billion | $481.72 Million | 0.06x | 0.40x |
| 2024 | $480.44 Million | $3.18 Billion | $410.09 Million | 0.15x | 1.17x |
| 2025 | $292.52 Million | $3.44 Billion | $673.42 Million | 0.09x | 0.43x |
| 2026 | $251.20 Million | $4.07 Billion | $775.12 Million | 0.06x | 0.32x |
Competitor Companies of VIMTALABS by Market Capitalization
Companies near Vimta Labs Limited in the global market cap rankings as of October 31, 2026. See debt-free asset ratio of Vimta Labs Limited to understand what proportion of total assets are financed by equity.
Key companies related to Vimta Labs Limited by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #136 globally with a market cap of $167.39 Billion USD.
- Natera Inc (NASDAQ:NTRA): Ranked #480 globally with a market cap of $56.33 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #525 globally with a market cap of $51.71 Billion USD ( CN¥353.41 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $709.18 |
| #136 | Danaher Corporation | NYSE:DHR | $167.39 Billion | $236.98 |
| #480 | Natera Inc | NASDAQ:NTRA | $56.33 Billion | $436.00 |
| #525 | WuXi AppTec Co Ltd | SHG:603259 | $51.71 Billion | CN¥142.89 |
Market Capitalization of Vimta Labs Limited (2015–2026)
Market capitalization of Vimta Labs Limited from 2015 to today. Between 2015 and today, Vimta Labs Limited's market cap moved from $46.99 Million to $ 251.20 Million, with a yearly change of 18.80%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs251.20 Million | -14.13% |
| 2025 | Rs292.52 Million | -39.11% |
| 2024 | Rs480.44 Million | +147.32% |
| 2023 | Rs194.26 Million | -7.08% |
| 2022 | Rs209.06 Million | +7.35% |
| 2021 | Rs194.74 Million | +136.96% |
| 2020 | Rs82.18 Million | +87.60% |
| 2019 | Rs43.81 Million | -70.10% |
| 2018 | Rs146.52 Million | +88.40% |
| 2017 | Rs77.77 Million | +61.93% |
| 2016 | Rs48.03 Million | +2.22% |
| 2015 | Rs46.99 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 30th, 2026 the market cap of Vimta Labs Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $251.20 Million USD |
| MoneyControl | $251.20 Million USD |
| MarketWatch | $251.20 Million USD |
| marketcap.company | $251.20 Million USD |
| Reuters | $251.20 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Vimta Labs Limited
Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract researc… Read more